SCHEMBL8085249

SCHEMBL8085249

O=C1Nc2ccccc2S/C1=C\c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.67
PIM3 Q86V86 1/20 0.67
PIM2 Q9P1W9 1/20 0.67
NPC1 O15118 4/20 0.64
RAB9A P51151 4/20 0.64
HTT P42858 1/20 0.64
NAT1 P18440 2/20 0.61
CA2 P00918 1/20 0.61
EPHX1 P07099 1/20 0.61
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
ALDH1A1 P00352 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
CDK5 Q00535 1/20 0.53
CDK5R1 Q15078 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HPGD P15428 4/20 0.53
AKR1B1 P15121 2/20 0.53
MAPT P10636 4/20 0.52
GAA P10253 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8085252 1.00 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL15571574 1.00 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL10805356 0.88 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL10817027 0.88 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL10805360 0.88 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL10817032 0.88 PIM1 (0.67) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL5746497 0.84 NPC1 (0.69) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL5746504 0.84 NPC1 (0.69) PIM1PIM3PIM2NPC1RAB9A
SCHEMBL1250387 0.80 PIM1 (1.00) PIM1PIM3PIM2RAB9ANAT1
SCHEMBL211085 0.80 PIM1 (1.00) PIM1PIM3PIM2RAB9ANAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0137083-A1 1,5-Benzothiazepine derivatives and production thereof HAMARI YAKUHIN KOGYO KABUSHIKI KAISHA also known as HAMARI CHEMICALS, LTD. (JP) 1985-04-17 EP claimed
EP-0627425-B1 3-OXO-1,4-BENZOTHIAZINE DERIVATIVE SANTEN PHARMACEUTICAL CO LTD (JP) 2000-11-02 EP disclosed
EP-0657444-B1 3-Oxo-1,4-benzothiazine derivates SANTEN PHARMACEUTICAL CO LTD (JP) 1999-03-31 EP disclosed
EP-0666261-B1 Thiazine or thiomorpholine derivatives SANTEN PHARMACEUTICAL CO LTD (JP) 1997-05-07 EP disclosed
US-5556841-A TREATMENT OF CATARACTS SANTEN PHARMACEUTICAL CO., LTD. (JP) 1996-09-17 US disclosed
US-5547952-A TREATMENT OF CATARACTS SANTEN PHARMACEUTICAL CO., LTD. (JP) 1996-08-20 US disclosed
US-5496817-A TREATMENT OF CATARACTS; SUPPRESSION OF LIPID PEROXIDE FORMATION SANTEN PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
EP-0666261-A1 Novel thiazine or thiomorpholine derivatives SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-08-09 EP disclosed
EP-0657444-A1 Novel 3-oxo-1, 4-benzothiazine derivatives SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-06-14 EP disclosed
EP-0627425-A1 3-OXO-1,4-BENZOTHIAZINE DERIVATIVE SANTEN PHARMACEUTICAL CO., LTD. (JP) 1994-12-07 EP disclosed
US-3923709-A 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines MONSANTO CO 1975-12-02 US disclosed